These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 2756322

  • 1. [Hypocalcemia induced in patients with Paget's disease by nasal salmon calcitonin. Effects of anti-calcitonin salmine antibodies].
    Reginster JY, Almer S, Gaspar S, Albert A, Deroisy R, Franchimont P.
    Rev Rhum Mal Osteoartic; 1989 Jun; 56(7):563-7. PubMed ID: 2756322
    [No Abstract] [Full Text] [Related]

  • 2. Influence of specific anti-salmon calcitonin antibodies on biological effectiveness of nasal salmon calcitonin in Paget's disease of bone.
    Reginster JY, Gennari C, Mautalen C, Deroisy R, Denis D, Lecart MP, Vandalem JL, Collette J, Franchimont P.
    Scand J Rheumatol; 1990 Jun; 19(1):83-6. PubMed ID: 2309107
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Editorial: salmon calcitonin in the treatment of Paget disease.
    Goldsmith RS.
    JAMA; 1975 Jun 16; 232(11):1156-7. PubMed ID: 1173622
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Calcitonin nasal spray for Paget's disease of the bone].
    Luboshitzky R, Bar-Shalom R.
    Harefuah; 1995 Mar 15; 128(6):358-62, 399. PubMed ID: 7750816
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of intranasal human calcitonin in patients with Paget's disease refractory to salmon calcitonin.
    Muff R, Dambacher MA, Perrenoud A, Simon C, Fischer JA.
    Am J Med; 1990 Aug 15; 89(2):181-4. PubMed ID: 2382666
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro detection of neutralizing antibodies after treatment of Paget's disease of bone with nasal salmon calcitonin.
    Grauer A, Raue F, Schneider HG, Frank-Raue K, Ziegler R.
    J Bone Miner Res; 1990 Apr 15; 5(4):387-91. PubMed ID: 2343778
    [Abstract] [Full Text] [Related]

  • 12. Salmon-calcitonin nasal spray in Paget's disease of bone: preliminary results in five patients.
    Reginster JY, Albert A, Franchimont P.
    Calcif Tissue Int; 1985 Dec 15; 37(6):577-80. PubMed ID: 3937575
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Development and significance of antibodies to salmon calcitonin in patients with Paget's disease on long-term treatment.
    Woodhouse NJ, Mohamedally SM, Saed-Nejad F, Martin TJ.
    Br Med J; 1977 Oct 08; 2(6092):927-9. PubMed ID: 410477
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of the acute effect of the intranasal and intramuscular administration of salmon calcitonin in Paget's disease.
    González D, Vega E, Ghiringhelli G, Mautalen C.
    Calcif Tissue Int; 1987 Dec 08; 41(6):313-5. PubMed ID: 3124939
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.